Indeed, the number of CD11b + Ly6C−F4/80 + cells was also higher in CI-deficient tumors (Fig. 6c), suggesting that CI deficiency in cancer may promote differentiation of CD11b + Ly6C + cells into macrophages (CD11b + Ly6C−F480 +). The gene discussed is ITGAM; the disease is cancer.